Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D Data Sharing Rule Allows External Researchers Access, With Limits

Executive Summary

CMS will permit outside groups to access Medicare Part D data for research, but with restrictions to protect both beneficiary confidentiality and commercially sensitive information, the agency says in its final rule on Part D data sharing

You may also be interested in...



CMS Virtual Research Data Center Streamlines Access To Medicare, Medicaid Information

Health care data that is currently available from CMS via physical delivery of encrypted files will now be available to researchers at their own workstations through a web-based system, enabling more timely access at a lower cost.

Influence Of Doctor/Pharma Relationships On Prescribing Habits May Be Next Big Congressional Inquiry; Sunshine Act Could Be Investigation Boon

If provisions in the Sunshine Act are included as part of a final health care reform bill, agencies would be able to directly estimate for Congress the financial impact of physician/pharma relationships on prescribing trends

Influence Of Doctor/Pharma Relationships On Prescribing Habits May Be Next Big Congressional Inquiry; Sunshine Act Could Be Investigation Boon

If provisions in the Sunshine Act are included as part of a final health care reform bill, agencies would be able to directly estimate for Congress the financial impact of physician/pharma relationships on prescribing trends

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS049679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel